ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2582

Increased Morbidity and Mortality in Female Versus Male Tumor Necrosis Factor-Transgenic Mice

Richard Bell1, Ronald Wood2, Joe Chakkalakal3, Christopher T. Ritchlin4, Edward Schwarz5 and Homaira Rahimi6, 1Pathology, University of Rochester, Rochester, NY, 2University of Rochester, Rochester, NY, 3Orthopaedics, University of Rochester, Rochester, NY, 4Allergy, Immunology and Rheumatology, University of Rochester, Rochester, NY, 5Orthopedeatrics, University of Rochester, Rochester, NY, 6Rheumatology, University of Rochester/Golisano Children's Hosp, Rochester, NY

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: animal models and tumor necrosis factor (TNF), hormones, morbidity and mortality, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Rheumatoid Arthritis - Animal Models Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Rheumatoid arthritis
(RA) is a chronic debilitating condition with a 2-3 fold greater prevalence in women
than men. Additionally, women have worse disease outcomes and a suspected increased
mortality.  However, the etiology of sex differences in RA remains unclear. Tumor
necrosis factor-transgenic (TNF-Tg) mice, a model of inflammatory arthritis,
display similar sex differences as RA patients.  To formally test the
hypothesis that female TNF-Tg mice have greater morbidity and mortality versus
male littermates, we assessed arthritic signs, function and time to death in a large
cohort of TNF-Tg mice and wild type (WT) controls. Methods: Male (n=30) and female (n=38) TNF-Tg
mice (3647 line) and WT littermates (n=33) were monitored over six months, and
dates of death were recorded for Kaplan-Meier analysis. Grip strength, as an
indicator of arthritis, and weight was measured in male and female TNF-Tg mice
with active arthritis at five months of age. The same measurements were taken
in a cohort of mice at two months of age, prior to onset of clinical signs, and
four weeks later when frank arthritis was present. Results: Female TNF-Tg mice have significantly
shorter median lifespans than males (5.9 vs 8.1 months, p<0.05) (Fig. 1). Male
and female TNF-Tg mice have significantly decreased normalized grip-strength at
five months of age compared to WT sex-matched controls (0.05±0.001 vs 0.03±0.004
vs 0.10±0.01 vs 0.01±0.001, p<0.0001). At two months of age, female TNF-Tg
mice have decreased normalized grip-strength compared to age-matched male
TNF-Tg and female WT mice (0.079±0.01 vs 0.095±0.02 vs 0.10±0.01, p<0.05).  Interestingly,
there was no clinical evidence of arthritis at this time.  However, four weeks
later, tarsal joint swelling and an inability to splay digits was noted in hind
limbs of TNF-Tg mice, which was indistinguishable between sexes. Moreover, female
TNF-Tg displayed a significantly decreased rate of weight gain measured from two
months to three months of age compared to male TNF-Tg and female WT mice (1.01±1.71%
vs 7.11±1.18% vs 12.53±2.08%, p<0.001). Conclusion: We show for the first time that
TNF-Tg female mice with chronic inflammatory arthritis have shorter lifespans
than male littermates. Grip-strength was decreased in female TNF-Tg earlier
than age-matched TNF males, indicating earlier onset of disease, although gross
signs of arthritis between sexes were not noted. Similarly, rate of growth as
measured by change in weight gain was decreased in female TNF-Tg mice at the
earliest manifestations of disease compared to male TNF-Tg mice. This is
similar to RA in which females are suggested to have increased morbidity and
mortality compared to males. Potential implications include sex hormone
interactions during TNF-mediated inflammation, raising the possibility that
modulating the hormonal environment could lessen the burden of RA in women.

Disclosure: R. Bell, None; R. Wood, None; J. Chakkalakal, None; C. T. Ritchlin, None; E. Schwarz, None; H. Rahimi, None.

To cite this abstract in AMA style:

Bell R, Wood R, Chakkalakal J, Ritchlin CT, Schwarz E, Rahimi H. Increased Morbidity and Mortality in Female Versus Male Tumor Necrosis Factor-Transgenic Mice [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/increased-morbidity-and-mortality-in-female-versus-male-tumor-necrosis-factor-transgenic-mice/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/increased-morbidity-and-mortality-in-female-versus-male-tumor-necrosis-factor-transgenic-mice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology